- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
U.S. Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
12
High return on equity, past performance and sound balance sheet.
12 companies
Medpace Holdings
Market Cap: US$9.1b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$305.28
7D
5.2%
1Y
-21.1%
Protagonist Therapeutics
Market Cap: US$2.6b
A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
PTGX
US$45.03
7D
4.2%
1Y
69.4%
Exelixis
Market Cap: US$9.9b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$35.74
7D
2.6%
1Y
57.4%
Agilent Technologies
Market Cap: US$29.3b
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
A
US$105.19
7D
1.5%
1Y
-25.0%
Catalyst Pharmaceuticals
Market Cap: US$2.7b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$22.80
7D
4.5%
1Y
48.1%
China SXT Pharmaceuticals
Market Cap: US$34.3m
A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.
SXTC
US$2.50
7D
-4.2%
1Y
-73.3%
Corcept Therapeutics
Market Cap: US$7.2b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$67.43
7D
-9.7%
1Y
191.3%
BioStem Technologies
Market Cap: US$215.6m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$12.89
7D
68.3%
1Y
11.1%
Puma Biotechnology
Market Cap: US$139.9m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$2.93
7D
3.5%
1Y
-45.2%
Earth Science Tech
Market Cap: US$35.7m
Focuses on health and wellness industry.
ETST
US$0.11
7D
-4.3%
1Y
92.8%
Maze Therapeutics
Market Cap: US$342.9m
A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.
MAZE
US$8.50
7D
-4.7%
1Y
n/a
Champions Oncology
Market Cap: US$100.6m
A technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States.
CSBR
US$7.90
7D
0%
1Y
58.0%